SEC Form 4 · accession 0001144204-17-049287
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William John Bush
Director
Period of report
Apr 21, 2017
Accepted (ET)
Sep 22, 2017 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 21, 2017 | A | 10,081 | $0.00 | A | 100,610 | D | |
| Common StockF2 | Jul 24, 2017 | A | 53,476 | $0.00 | A | 154,086 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock issued pursuant to the company's 2015 Incentive Compensation Plan and vested immediately.
- F2Consists of restricted stock issued pursuant to the company's 2015 Incentive Compensation Plan and vesting in four equal installments each quarter over the next year.